Novo Nordisk spent millions on weight loss searches that took people to Ozempic website

Taking stock of the drug industry, from the lab to the medicine chest

November 3, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Mario Tama/Getty Images STAT+ | Novo Nordisk spent millions on weight loss searches that took people to its Ozempic website, analysis found Novo Nordisk argued, however, that it is not accurate to suggest the company paid for certain keywords and phrases By Ed Silverman STAT+ | UniQure's FDA submission for its Huntington's disease therapy thrown into question The company said the agency had changed its position on what level of data were sufficient for it to apply for approval for its gene therapy. By Andrew Joseph STAT+ | Pfizer files second lawsuit against Novo Nordisk, Metsera in battle over obesity startup The pharma giant alleges in the suit that the bid for the weight loss startup by the Danish drugmaker is anticompetitive. By Elaine Chen Caribou Biosciences STAT+ | Caribou's off-the-shelf CAR-T therapy shows promise in lymphoma study Caribou's vespa-cel CAR-T therapy can be made more quickly, stored, and then given to patients on demand. By Adam Feuerstein Opinion: The big flaw in Big Pharma's 'patient advocacy' Big Pharma spends millions on patient advocacy — but it often doesn't help patients By Will Greene

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser